In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes ... more emphasis on the use of cystatin C for assessment of glomerular filtration rate; use of ...

With over 50 million Americans living with autoimmune diseases, the need for advanced clinical trial solutions has become increasingly urgent. YPrime’s TSJC assessment aims to meet this demand ...

In rare diseases, research into novel new techniques such as CRISPR, base editing, and prime editing will continue, following the first FDA clinical trial clearance for the latter in 2024 from ...

A panelist discusses how graft-vs-host disease (GVHD) manifests through a complex constellation of symptoms affecting multiple organ systems, including the skin (rash, itching), gastrointestinal tract ...

WEDNESDAY, March 19, 2025 (HealthDay News) -- In a 2024 clinical practice guideline issued by the Kidney Disease ... on the use of cystatin C for assessment of glomerular filtration rate; use ...

Roche outlined how digital health technologies (DHTs) provide more sensitive measures of disease progression in early ...

People who live with chronic diseases such as chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), connective tissue diseases (CTD), chronic kidney disease (CKD), liver ...